Reducing Adverse Vascular Outcomes With Factor XI Inhibition in Adult Participants With Peripheral Artery Disease

NCT07318610 · clinicaltrials.gov ↗

PHASE3

Phase

NOT_YET_RECRUITING

Status

7050

Enrollment

INDUSTRY

Sponsor class

Conditions

Peripheral Artery Disease (PAD)

Interventions

DRUG: REGN7508
DRUG: REGN9933
DRUG: Placebo
DRUG: Rivaroxaban

Sponsor

Regeneron Pharmaceuticals